Psychological distress and tumor cell β2-adrenergic receptor levels in patients with surgically resected non-small cell lung cancer

Authors

  • Hronn Hardardottir Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Respiratory Medicine, Landspitali University Hospital, Reykjavik, Iceland https://orcid.org/0000-0002-1421-1461
  • Thor Aspelund Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland https://orcid.org/0000-0002-7998-5433
  • Bryndis Valdimarsdottir Stem Cell Research Unit, BioMedical Center, School of Health Sciences, University of Iceland, Reykjavík, Iceland https://orcid.org/0009-0000-3573-9276
  • Jurate Asmundsson Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland https://orcid.org/0000-0001-9104-9413
  • Vigdis Petursdottir Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland https://orcid.org/0009-0009-8152-4546
  • Katja Fall Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden; Institute of Environmental Medicine, Karolinska Instituted, Stockholm, Sweden https://orcid.org/0000-0002-3649-2639
  • Erika Broström Department of Immunology, Genetics and Pathology, Clinical and experimental pathology, Uppsala University, Uppsala, Sweden; Department of Medical Sciences, Respiratory-, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden https://orcid.org/0000-0003-1354-769X
  • Heiddis Valdimarsdottir Department of Psychology, Reykjavik University, Reykjavik, Iceland; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA https://orcid.org/0000-0001-9976-0007
  • Fang Fang Institute of Environmental Medicine, Karolinska Instituted, Stockholm, Sweden https://orcid.org/0000-0002-3310-6456
  • Magnus K. Magnusson Department of Medicine, Faculty of Medicine, University of Iceland, Reykjavík, Iceland; deCODE genetics/Amgen Inc., Reykjavík, Iceland https://orcid.org/0000-0001-8593-4934
  • Thorarinn Gudjonsson Stem Cell Research Unit, BioMedical Center, School of Health Sciences, University of Iceland, Reykjavík, Iceland; Department Laboratory Hematology, Landspitali University Hospital, Reykjavik, Iceland https://orcid.org/0000-0001-9645-9665
  • Tomas Gudbjartsson Department of Medicine, Faculty of Medicine, University of Iceland, Reykjavík, Iceland; Department of Cardiothoracic Surgery, Landspitali University Hospital, Reykjavik, Iceland https://orcid.org/0000-0002-7281-5749
  • Erica K. Sloan Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia https://orcid.org/0000-0002-2355-1433
  • Susan K. Lutgendorf Department of Psychological and Brain Sciences, University of Iowa, Iowa City, Iowa, USA https://orcid.org/0000-0003-3793-5881
  • Christer Jansson Department of Medical Sciences, Respiratory-, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden https://orcid.org/0000-0001-5093-6980
  • Unnur A. Valdimarsdottir Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Institute of Environmental Medicine, Karolinska Instituted, Stockholm, Sweden; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA https://orcid.org/0000-0001-5382-946X

DOI:

https://doi.org/10.2340/ao.v65.45317

Downloads

Download data is not yet available.

References

Vehling S, Mehnert-Theuerkauf A, Philipp R, Härter M, Kraywinkel K, Kuhnert R, et al. Prevalence of mental disorders in patients with cancer compared to matched controls – secondary analysis of two nationally representative surveys. Acta Oncol. 2022;61(1):7–13. DOI: https://doi.org/10.1080/0284186X.2021.1992008

Wang YH, Li JQ, Shi JF, Que JY, Liu JJ, Lappin JM, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020;25(7):1487–99. DOI: https://doi.org/10.1038/s41380-019-0595-x

Lutgendorf SK, Sood AK. Biobehavioral factors and cancer progression: physiological pathways and mechanisms. Psychosom Med. 2011;73(9):724–30. DOI: https://doi.org/10.1097/PSY.0b013e318235be76

Chang A, Sloan EK, Antoni MH, Knight JM, Telles R, Lutgendorf SK. Biobehavioral pathways and cancer progression: insights for improving well-being and cancer outcomes. Integr Cancer Ther. 2022;21:15347354221096081. DOI: https://doi.org/10.1177/15347354221096081

Pan C, Wu J, Zheng S, Sun H, Fang Y, Huang Z, et al. Depression accelerates gastric cancer invasion and metastasis by inducing a neuroendocrine phenotype via the catecholamine/β(2) -AR/MACC1 axis. Cancer Commun (Lond). 2021;41(10):1049–70. DOI: https://doi.org/10.1002/cac2.12198

Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12(8):939–44. https://doi.org/10.1038/nm1447 DOI: https://doi.org/10.1038/nm1447

Geerse OP, Brandenbarg D, Kerstjens HAM, Berendsen AJ, Duijts SFA, Burger H, et al. The distress thermometer as a prognostic tool for one-year survival among patients with lung cancer. Lung Cancer. 2019;130:101–7. DOI: https://doi.org/10.1016/j.lungcan.2019.02.008

Eckerling A, Ricon-Becker I, Sorski L, Sandbank E, Ben-Eliyahu S. Stress and cancer: mechanisms, significance and future directions. Nat Rev Cancer. 2021;21(12):767–85. DOI: https://doi.org/10.1038/s41568-021-00395-5

Wu Y, Zhou L, Zhang X, Yang X, Niedermann G, Xue J. Psychological distress and eustress in cancer and cancer treatment: advances and perspectives. Sci Adv. 2022;8(47):eabq7982. DOI: https://doi.org/10.1126/sciadv.abq7982

Creed SJ, Le CP, Hassan M, Pon CK, Albold S, Chan KT, et al. β2-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion. Breast Cancer Res. 2015;17(1):145. DOI: https://doi.org/10.1186/s13058-015-0655-3

Hanahan D, Monje M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell. 2023;41(3):573–80. DOI: https://doi.org/10.1016/j.ccell.2023.02.012

Rains SL, Amaya CN, Bryan BA. Beta-adrenergic receptors are expressed across diverse cancers. Oncoscience. 2017;4(7–8):95–105. DOI: https://doi.org/10.18632/oncoscience.357

Zhang Y, Zanos P, Jackson IL, Zhang X, Zhu X, Gould T, et al. Psychological stress enhances tumor growth and diminishes radiation response in preclinical model of lung cancer. Radiother Oncol. 2020;146:126–35. DOI: https://doi.org/10.1016/j.radonc.2020.02.004

Yazawa T, Kaira K, Shimizu K, Shimizu A, Mori K, Nagashima T, et al. Prognostic significance of beta2-adrenergic receptor expression in non-small cell lung cancer. Am J Transl Res. 2016;8(11):5059–70.

Kaira K, Kamiyoshihara M, Kawashima O, Endoh H, Imaizumi K, Sugano M, et al. Prognostic impact of beta2 adrenergic receptor expression in surgically resected pulmonary pleomorphic carcinoma. Anticancer Res. 2019;39(1):395–403. DOI: https://doi.org/10.21873/anticanres.13125

Hu P, He J, Liu S, Wang M, Pan B, Zhang W. beta2-adrenergic receptor activation promotes the proliferation of A549 lung cancer cells via the ERK1/2/CREB pathway. Oncol Rep. 2016;36(3):1757–63. DOI: https://doi.org/10.3892/or.2016.4966

Chang A, Le CP, Walker AK, Creed SJ, Pon CK, Albold S, et al. β2-Adrenoceptors on tumor cells play a critical role in stress-enhanced metastasis in a mouse model of breast cancer. Brain Behav Immun. 2016;57:106–15. DOI: https://doi.org/10.1016/j.bbi.2016.06.011

Le CP, Nowell CJ, Kim-Fuchs C, Botteri E, Hiller JG, Ismail H, et al. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination. Nat Commun. 2016;7:10634. DOI: https://doi.org/10.1038/ncomms10634

Santos-Sousa AL, Kayahara GM, Bastos DB, Sarafim-Silva BAM, Crivelini MM, Valente VB, et al. Expression of β(1)- and β(2)-adrenergic receptors in oral squamous cell carcinoma and their association with psychological and clinical factors. Arch Oral Biol. 2024;162:105939. DOI: https://doi.org/10.1016/j.archoralbio.2024.105939

Hardardottir H, Aspelund T, Fall K, Broström E, Sigurdsson BB, Cook E, et al. Psychobiological stress response to a lung cancer diagnosis: a prospective study of patients in Iceland and Sweden. Acta Oncol. 2023;62(10):1338–47. DOI: https://doi.org/10.1080/0284186X.2023.2258445

Hardardottir H, Aspelund T, Zhu J, Fall K, Hauksdottir A, Fang F, et al. Optimal communication associated with lower risk of acute traumatic stress after lung cancer diagnosis. Support Care Cancer. 2022;30(1):259–69. DOI: https://doi.org/10.1007/s00520-021-06138-4

Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70. DOI: https://doi.org/10.1111/j.1600-0447.1983.tb09716.x

Singer S, Kuhnt S, Gotze H, Hauss J, Hinz A, Liebmann A, et al. Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer. 2009;100(6):908–12. DOI: https://doi.org/10.1038/sj.bjc.6604952

Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51. DOI: https://doi.org/10.1016/j.jtho.2015.09.009

Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 2015;10(9):1240–2. DOI: https://doi.org/10.1097/JTO.0000000000000663

Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, et al. The 2021 WHO Classification of Lung Tumors: impact of advances since 2015. J Thorac Oncol. 2022;17(3):362–87. DOI: https://doi.org/10.1016/j.jtho.2021.11.003

Shimizu A, Kaira K, Mori K, Kato M, Shimizu K, Yasuda M, et al. Prognostic significance of beta2-adrenergic receptor expression in malignant melanoma. Tumour Biol. 2016;37(5):5971–8. DOI: https://doi.org/10.1007/s13277-015-4420-0

van Buuren S, Groothuis-Oudshoorn CG. mice: multivariate imputation by chained equation in R. J Stat Softw. 2011;45(3):1–67. DOI: https://doi.org/10.18637/jss.v045.i03

R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2014.

Bastos DB, Sarafim-Silva BAM, Sundefeld M, Ribeiro AA, Brandão JDP, Biasoli É R, et al. Circulating catecholamines are associated with biobehavioral factors and anxiety symptoms in head and neck cancer patients. PLoS One. 2018;13(8):e0202515. DOI: https://doi.org/10.1371/journal.pone.0202515

Jang HJ, Boo HJ, Lee HJ, Min HY, Lee HY. Chronic stress facilitates lung tumorigenesis by promoting exocytosis of IGF2 in lung epithelial cells. Cancer Res. 2016;76(22):6607–19. DOI: https://doi.org/10.1158/0008-5472.CAN-16-0990

Lutgendorf SK, DeGeest K, Dahmoush L, Farley D, Penedo F, Bender D, et al. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun. 2011;25(2):250–5. DOI: https://doi.org/10.1016/j.bbi.2010.10.012

Choi H, Mazzone P. Preoperative evaluation of the patient with lung cancer being considered for lung resection. Curr Opin Anaesthesiol. 2015;28(1):18–25. DOI: https://doi.org/10.1097/ACO.0000000000000149

Xia Y, Wei Y, Li ZY, Cai XY, Zhang LL, Dong XR, et al. Catecholamines contribute to the neovascularization of lung cancer via tumor-associated macrophages. Brain Behav Immun. 2019;81:111–21. DOI: https://doi.org/10.1016/j.bbi.2019.06.004

Zhang X, Zhang Y, He Z, Yin K, Li B, Zhang L, et al. Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2. Cell Death Dis. 2019;10(11):788. DOI: https://doi.org/10.1038/s41419-019-2030-2

Zhang ZF, Feng XS, Chen H, Duan ZJ, Wang LX, Yang D, et al. Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection. BMC Gastroenterol. 2016;16(1):57. DOI: https://doi.org/10.1186/s12876-016-0474-8

Garramona FT, Cunha TF, Vieira JS, Borges G, Santos G, de Castro G, et al. Increased sympathetic nervous system impairs prognosis in lung cancer patients: a scoping review of clinical studies. Lung Cancer Manag. 2023;12(4):Lmt63. DOI: https://doi.org/10.2217/lmt-2023-0006

Udumyan R, Montgomery S, Fang F, Valdimarsdottir U, Hardardottir H, Ekbom A, et al. Beta-blocker use and lung cancer mortality in a nationwide cohort study of patients with primary non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2020;29(1):119–26. DOI: https://doi.org/10.1158/1055-9965.EPI-19-0710

Additional Files

Published

2026-05-04

How to Cite

Hardardottir, H., Aspelund, T., Valdimarsdottir, B., Asmundsson, J., Petursdottir, V., Fall, K., … Valdimarsdottir, U. A. (2026). Psychological distress and tumor cell β2-adrenergic receptor levels in patients with surgically resected non-small cell lung cancer. Acta Oncologica, 65, 370–374. https://doi.org/10.2340/ao.v65.45317